Biotechnology Engineer , Instituto Tecnológico de Sonora, México
Ph.D. Molecular microbiology. Universidad Nacional Autónoma de México. 2008. México.

Líneas de Investigación

Ecophysiology of bacteria



Zhang Y., Blaby-Haas C.E., Steimle S., Verissimo A.F., Garcia-Angulo V.A., Koch H.G., Daldal F., Khalfaoui-Hassani B.2019. Cu Transport by the Extended Family of CcoA-like Transporters (CalT) in Proteobacteria. United Kingdom. Scientific Reports. ISSN 2045-2322. Impact factor: 4.12

Sepúlveda-Cisternas, I., Salazar, J.C. and García-Angulo, V.A. 2018. Overview on the bacterial iron-riboflavin metabolic axis.Switzerland. Frontiers in Microbiology. ISSN 1664-302X. Impact factor: 4.01.

Sepúlveda-Cisternas, I., Lozano, L., Fuentes-Flores, A., Vázquez, I. and García-Angulo, V.A.2018. Transcriptomics reveals a cross-modulatory effect between riboflavin and iron and outlines responses to riboflavin biosynthesis and uptake in Vibrio cholerae. United Kingdom. Scientific Reports. ISSN 2045-2322. Impact factor: 4.12.

Fuentes-Flores, A., Sepúlveda-Cisternas, I., Vásquez, I., Torres, A. and García-Angulo, V.A. 2107. Contribution of riboflavin supply pathways to Vibrio choleraein different environments. U.K.,Gut Pathogens. ISSN: 1757-4749. Impact factor: 2.80

Sepúlveda-Cisternas, I., Torres, A., Fuentes-Flores, A. and García-Angulo, V.A. 2017. Differential regulation of riboflavin supply pathways in Vibrio cholerae. U.K., Gut Pathogens. ISSN: 1757-4749. Impact factor: 2.80

García-Angulo, V.A. Overlapping riboflavin supply pathways in bacteria. 2017. U.K., Critical Reviews in Microbiology. ISSN: 1040-841X. Impact factor: 4.73

Gutiérrez-Preciado, A., Torres, A. G., Bonomi, H., Goldbaum, F.A. and García-Angulo V. A. Extensive Identification of bacterial riboflavin transporters and their distribution across bacterial species. 2015. USA. PLOS One. ISSN: 1932-6203. Impact factor: 2.76.

García-Angulo, V. A., Kalita, A., Kalita, M., Lozano, L. and Torres A. G.  A comparative genomics and immunoinformatics approach for the identification of vaccine candidates against enterohemorrhagicEscherichia coli. 2014. USA. Infection and Immunity. ISSN: 0019-9567. Impact factor: 3.25.